ENTEROTOXIGENIC ESCHERICHIA COLI INFECTION

Clinical trials for ENTEROTOXIGENIC ESCHERICHIA COLI INFECTION explained in plain language.

Never miss a new study

Get alerted when new ENTEROTOXIGENIC ESCHERICHIA COLI INFECTION trials appear

Sign up with your email to follow new studies for ENTEROTOXIGENIC ESCHERICHIA COLI INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Scientists test live oral vaccine to block two major causes of Traveler's diarrhea

⭐️ VACCINE ⭐️ Completed

This early-stage study tested the safety and immune response of a new oral vaccine designed to prevent two common bacterial causes of severe diarrhea: Shigella and a type of E. coli (ETEC). Healthy adult volunteers received either the vaccine or a placebo in a single dose, and re…

Matched conditions: ENTEROTOXIGENIC ESCHERICHIA COLI INFECTION

Phase: PHASE1 • Sponsor: University of Maryland, Baltimore • Aim: ⭐️ VACCINE ⭐️

Last updated Mar 23, 2026 15:16 UTC

ENTEROTOXIGENIC ESCHERICHIA COLI INFECTION

Get alerted when new ENTEROTOXIGENIC ESCHERICHIA COLI INFECTION trials appear

Scientists test live oral vaccine to block two major causes of Traveler's diarrhea